Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”

Published:2022-12-31 Issue:4 Volume:27 Page:245-246
ISSN:2287-1012
Container-title:Annals of Pediatric Endocrinology & Metabolism
language:en
Short-container-title:Ann Pediatr Endocrinol Metab

Author:

Kim Ji Hyun^ORCID

Publisher

Korean Society of Pediatric Endocrinology

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

http://e-apem.org/upload/pdf/apem-2222019edi04.pdf

Reference8 articles.

1. Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease

2. Methimazole-induced remission rates in pediatric Graves’ disease: a systematic review

3. 2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease

4. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves’ disease: a single-center experience

5. Predictors of Autoimmune Hyperthyroidism Relapse in Children after Discontinuation of Antithyroid Drug Treatment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in the Management of Graves Disease in Children;The Ewha Medical Journal;2023-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP